These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 37298571)

  • 1. Can Allostery Be a Key Strategy for Targeting PTP1B in Drug Discovery? A Lesson from Trodusquemine.
    Maccari R; Ottanà R
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders.
    Singh S; Singh Grewal A; Grover R; Sharma N; Chopra B; Kumar Dhingra A; Arora S; Redhu S; Lather V
    Bioorg Chem; 2022 Apr; 121():105626. PubMed ID: 35255350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional properties of Claramine: a novel PTP1B inhibitor and insulin-mimetic compound.
    Qin Z; Pandey NR; Zhou X; Stewart CA; Hari A; Huang H; Stewart AF; Brunel JM; Chen HH
    Biochem Biophys Res Commun; 2015 Feb; 458(1):21-7. PubMed ID: 25623533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of research on natural protein tyrosine phosphatase 1B inhibitors as potential antidiabetic agents: Update.
    Liu Z; Gao H; Zhao Z; Huang M; Wang S; Zhan J
    Biomed Pharmacother; 2023 Jan; 157():113990. PubMed ID: 36459712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein tyrosine phosphatase 1B (PTP1B) function, structure, and inhibition strategies to develop antidiabetic drugs.
    Coronell-Tovar A; Pardo JP; Rodríguez-Romero A; Sosa-Peinado A; Vásquez-Bochm L; Cano-Sánchez P; Álvarez-Añorve LI; González-Andrade M
    FEBS Lett; 2024 Aug; 598(15):1811-1838. PubMed ID: 38724486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine phosphatase 1B (PTP1B) and obesity.
    Cho H
    Vitam Horm; 2013; 91():405-24. PubMed ID: 23374726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B.
    Ottanà R; Paoli P; Lori G; Adornato I; Previti S; Naß A; Wolber G; Maccari R
    Bioorg Chem; 2019 Nov; 92():103211. PubMed ID: 31491569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Library of Thiazolidin-4-one Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: An Attempt To Discover Novel Antidiabetic Agents.
    Patel AD; Pasha TY; Lunagariya P; Shah U; Bhambharoliya T; Tripathi RKP
    ChemMedChem; 2020 Jul; 15(13):1229-1242. PubMed ID: 32390300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview.
    Khator R; Biharee A; Bhatia N; Kulkarni S; Singh Y; Karthikeyan C; Jain AK; Thareja S
    Curr Med Chem; 2024; 31(34):5535-5549. PubMed ID: 37711015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015-2018).
    Hussain H; Green IR; Abbas G; Adekenov SM; Hussain W; Ali I
    Expert Opin Ther Pat; 2019 Sep; 29(9):689-702. PubMed ID: 31402706
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice.
    Lantz KA; Hart SG; Planey SL; Roitman MF; Ruiz-White IA; Wolfe HR; McLane MP
    Obesity (Silver Spring); 2010 Aug; 18(8):1516-23. PubMed ID: 20075852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus.
    Nandi S; Saxena M
    Curr Top Med Chem; 2020; 20(29):2692-2707. PubMed ID: 32888269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models.
    Krishnan N; Konidaris KF; Gasser G; Tonks NK
    J Biol Chem; 2018 Feb; 293(5):1517-1525. PubMed ID: 29217773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
    Eleftheriou P; Geronikaki A; Petrou A
    Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.
    Ghareb N; El-Sayed NM; Abdelhameed R; Yamada K; Elgawish MS
    Bioorg Chem; 2019 May; 86():322-338. PubMed ID: 30743173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive review on the research progress of PTP1B inhibitors as antidiabetics.
    Agrawal N; Dhakrey P; Pathak S
    Chem Biol Drug Des; 2023 Oct; 102(4):921-938. PubMed ID: 37232059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric inhibition of protein tyrosine phosphatase 1B.
    Wiesmann C; Barr KJ; Kung J; Zhu J; Erlanson DA; Shen W; Fahr BJ; Zhong M; Taylor L; Randal M; McDowell RS; Hansen SK
    Nat Struct Mol Biol; 2004 Aug; 11(8):730-7. PubMed ID: 15258570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine phosphatase 1B in metabolic diseases and drug development.
    Delibegović M; Dall'Angelo S; Dekeryte R
    Nat Rev Endocrinol; 2024 Jun; 20(6):366-378. PubMed ID: 38519567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Protein Tyrosine Phosphatase 1B Targeted Drug Discovery for Type II Diabetes and Obesity.
    Maheshwari N; Karthikeyan C; Trivedi P; Moorthy NSHN
    Curr Drug Targets; 2018; 19(5):551-575. PubMed ID: 28228082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico investigations on the binding efficacy and allosteric mechanism of six different natural product compounds towards PTP1B inhibition through docking and molecular dynamics simulations.
    SarathKumar B; Lakshmi BS
    J Mol Model; 2019 Aug; 25(9):272. PubMed ID: 31451955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.